NCT01999400View on ClinicalTrials.gov

Correlation of Mesalamine Pharmacokinetics With Local Availability

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

September 30, 2015

Study Completion Date

April 30, 2017

Conditions
Local Drug Concentration in Gastrointestinal Tract
Interventions
DRUG

Pentasa 500 mg capsule x 2 with 240 mL water; single dose

DRUG

Apriso 375 mg capsule x 3 with 240 mL water; single dose

DRUG

Lialda 1200 mg tablet x 1 with 240 mL water; single dose

DRUG

Delzicol 100 mg mesalamine x 1 with 245 mL water; single dose

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
collaborator

Food and Drug Administration (FDA)

FED

lead

University of Michigan

OTHER

NCT01999400 - Correlation of Mesalamine Pharmacokinetics With Local Availability | Biotech Hunter | Biotech Hunter